UP Court upholds restraint on Canada’s Jamp Pharma and third parties from infringing Jubilant Generics Limited’s IPR and confidential proprietary information
The Court has upheld a restraint against Canada’s Jamp Pharma and associated third parties, preventing them from infringing upon Jubilant Generics Limited’s intellectual property rights and unauthorized use of its confidential product dossier reinforcing the importance of respecting cross-border confidentiality agreements in pharmaceutical manufacturing and distribution.
